Presentations

 Invited Presentations (2001-2011)
(60 presentations in major national/international meetings and pharmaceutical companies during the past 10 years; only a short list of 25 selected publications is given below)

  • Challenges and Strategies in the Early-Stage Development of Poorly Water-Soluble Drugs(Keynote Presentation).AAPS Northeast Regional Discussion Group Annual Meeting,Rocky Hill, CT, April 15 2011.
  • Formulation of Poorly Water-Soluble Drugs: Drug Delivery Strategies.AAPS Research Achievement Award Winner Lecture. AAPS Annual Meeting,New Orleans, LA, November 2010.
  • Early Development of Poorly Water-Soluble NCEs: Potential Advantages of Keeping Development Activities in house,AAPS Annual Meeting, Los Angeles, CA, November 2009.
  • Oral Delivery of Poorly Water-Soluble Drugs: In situ Nanoparticle Formation Applying Nanoemulsion and Solid Dispersion Technologies,AAPS Annual Meeting, Los Angeles, CA, November 2009.
  • Development of Solid Dispersions and High Energy Solids to Enhance Solubility and Dissolution Rate of Solid Dosage Forms, AAPS Workshop on Evolving Science and Technology in Physical Pharmacy and Biopharmaceutics, Baltimore, Maryland, May 13 – 15, 2009
  • Salt selection and optimization for new chemical entities, AAPS Webinar, American Association of Pharmaceutical Scientists, 12:30-2:00 PM EDST, April 14, 2009
  • Lipid-based solid dispersion for oral delivery, AAPS Workshop on Scientific and Technological Advances in the Use of Lipid-based Drug Delivery Systems for Bioavailability Enhancement and Tissue Targeting, Baltimore, MA, March 10-11, 2009
  • Challenges and strategies in dosage form development of the new generation of poorly water-soluble drugs. Bay Area Discussion Group (BADG), San Mateo, CA, January 29, 2009
  • Development of surfactant and lipid-based solid dispersions and solid microemulsion preconcentrates for oral delivery of poorly water-soluble drugs. American Chemical Society- New York Chapter, Westchester, NY, November 2008.
  • Liquid and Solid Microemulsion Preconcentrate Systems for Oral Delivery. AAPS Annual Meeting, Atlanta, GA, November 2008.
  • Relevance of Physicochemical Characteristics in Dissolution and Drug Product Development. AAPS Workshop on the Role of Dissolution in QbD and Drug Product Life Cycle, Arlington, VA, April, 2008.
  • Drug-Excipient Compatibility Screening. AAPS Annual Meeting Short Course, November, 2005.
  • Application of Solid Dispersion in the Development of Poorly Water-Soluble Drugs. CPA/AAPS Joint Conference on Current Status and Future Trends in Drug Delivery Systems, Shenyang, China, September, 2005.
  • Physical Pharmaceutics of Poorly Water-Soluble drugs. CPA/AAPS Joint Conference on Current Status and Future Trends in Drug Delivery Systems, Shenyang, China, September, 2005.
  • In Silico Prediction of and Software Simulation as a Platform to Identify Absorption Rate Limiting Factors in Early Product Development. AAPS Annual Meeting Symposium, November, 2004.
  • Current Trends in Formulation and Bioavailability Enhancement by Solid Dispersion. AAPS Pharmaceutics and Drug Delivery Conference, Philadelphia, June, 2004.
  • Product Life Cycle Management. CPA/AAPS Joint Symposium on Pharmaceutical Science, Shanghai, China, November, 2003.
  • Solid Dispersion in PEG-Surfactant Systems. CPA/AAPS Joint Symposium on Pharmaceutical Science, Shanghai, China, November, 2003.
  • Recent Trends in Drug Delivery Systems. CPA/AAPS Joint Symposium on Pharmaceutical Science, Shanghai, China, November, 2003.
  • How Graduate Education in Pharmaceutics is Meeting its Objectives: An Industrial Scientist’s Perspective. AAPS Annual Meeting Roundtable, Salt Lake City, UT, October, 2003.
  • Education Beyond Graduate Studies to Become Successful Industrial Scientists: Perspective of a Preformulation/Formulation Scientist. AAPS Annual Meeting Symposium, Toronto,Canada, November, 2002.
  • A Systematic Approach to the Identification of Chemical and Physical Forms. AAPS Workshop on Chemical and Physical Form Selection of Drug Candidates: Principles, Considerations and Case Studies, Arlington, VA, April, 2002.
  • Selection of Scalable Phase I Formulation. AAPS Pharmaceutics and Drug Delivery Conference, Arlington, VA, April, 2002.
  • The Future of Pharmaceutics and Drug Delivery AAPS Pharmaceutics and Drug Delivery Conference, Arlington, VA, April, 2002(Keynote Presentation in the General Session).
  • Lipid-Based Systems for Oral Drug Delivery: Enhancing the Bioavailability of Poorly Soluble Drugs. AAPS Pharmaceutics and Drug Delivery Conference, Arlington, VA, April, 2002.